705 related articles for article (PubMed ID: 26294067)
61. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
[TBL] [Abstract][Full Text] [Related]
62. Prognostic factors in IgD myeloma: a study of 21 cases.
Fibbe WE; Jansen J
Scand J Haematol; 1984 Nov; 33(5):471-5. PubMed ID: 6515330
[TBL] [Abstract][Full Text] [Related]
63. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].
Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B
Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612
[TBL] [Abstract][Full Text] [Related]
64. [Renal disease in myeloma. Role of the tumor cell mass (author's transl)].
San Miguel J; Batlle J; Alberca I; Moraleda JM; López Borrasca A
Med Clin (Barc); 1981 Apr; 76(8):347-9. PubMed ID: 7253752
[TBL] [Abstract][Full Text] [Related]
65. IgD myeloma: clinical, biological and laboratory features.
Sinclair D
Clin Lab; 2002; 48(11-12):617-22. PubMed ID: 12465746
[TBL] [Abstract][Full Text] [Related]
66. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
67. [Laboratory diagnosis of monoclonal gammopathies. Prospective study of 14 cases in Dakar, Senegal].
Diop PA; Haudrechy D; Sylla-Niang M; Diedhiou A; Ngom L; Lopez-Sall P
Bull Soc Pathol Exot; 1998; 91(3):242-6. PubMed ID: 9773201
[TBL] [Abstract][Full Text] [Related]
68. [Determination of light chains in serum].
Hansen CT; Nielsen L; Münster AM; Abildgaard N
Ugeskr Laeger; 2010 Aug; 172(34):2302-5. PubMed ID: 20727297
[TBL] [Abstract][Full Text] [Related]
69. Lambda Light Chain Non-crystalline Proximal Tubulopathy with IgD Lambda Myeloma.
Kishi S; Obata F; Miki H; Matsuura M; Nishimura K; Tamaki M; Kishi F; Murakami T; Abe H; Nagai K; Abe M; Doi T
Intern Med; 2018 Dec; 57(24):3597-3602. PubMed ID: 30101939
[TBL] [Abstract][Full Text] [Related]
70. Light chain multiple myeloma: an evaluation of its biochemical investigations.
Zahari Sham SY; C Thambiah S; Samsudin IN; Lim SM
Malays J Pathol; 2017 Dec; 39(3):311-315. PubMed ID: 29279596
[TBL] [Abstract][Full Text] [Related]
71. Diagnostic reference range of κ/λ free light chain ratio to screen for Bence Jones proteinuria is not significantly influenced by GFR.
Schmidt-Hieltjes Y; Elshof C; Roovers L; Ruinemans-Koerts J
Eur J Haematol; 2016 May; 96(5):527-31. PubMed ID: 26172558
[TBL] [Abstract][Full Text] [Related]
72. The relationship between the serum free light chain assay and serum immunofixation electrophoresis, and the definition of concordant and discordant free light chain ratios.
Singhal S; Vickrey E; Krishnamurthy J; Singh V; Allen S; Mehta J
Blood; 2009 Jul; 114(1):38-9. PubMed ID: 19411633
[TBL] [Abstract][Full Text] [Related]
73. The evolving use of serum free light chain assays in haematology.
Pratt G
Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
[TBL] [Abstract][Full Text] [Related]
74. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component.
Fine JM; Rivat C; Lambin P; Ropartz C
Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767
[No Abstract] [Full Text] [Related]
75. Serum free light chain (FLC) measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins.
Bakshi NA; Gulbranson R; Garstka D; Bradwell AR; Keren DF
Am J Clin Pathol; 2005 Aug; 124(2):214-8. PubMed ID: 16040291
[TBL] [Abstract][Full Text] [Related]
76. Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: preliminary quantitative study.
Granger Vallée A; Chenine L; Leray-Moragues H; Patrier L; Cognot C; Cartron G; Cristol JP; Canaud B
Nephrol Dial Transplant; 2011 Nov; 26(11):3627-33. PubMed ID: 21508098
[TBL] [Abstract][Full Text] [Related]
77. Prognostic Value of Serum Free Light Chain in Multiple Myeloma.
El Naggar AA; El-Naggar M; Mokhamer el-H; Avad MW
Egypt J Immunol; 2015; 22(1):69-78. PubMed ID: 26415374
[TBL] [Abstract][Full Text] [Related]
78. [Clinical value of the blood measurement of the free light chains of immunoglobulins].
Bidet A; Marit G; Bérard AM
Ann Biol Clin (Paris); 2008; 66(4):427-31. PubMed ID: 18725344
[TBL] [Abstract][Full Text] [Related]
79. Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
Beaumont-Epinette MP; Moreau C; Besnard S; Latute F; Collet N; Sebillot M; Grosbois B; Bendavid C; Guenet L; Decaux O
Pathol Biol (Paris); 2015 Sep; 63(4-5):215-21. PubMed ID: 26319969
[TBL] [Abstract][Full Text] [Related]
80. Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
Nowrousian MR; Brandhorst D; Sammet C; Kellert M; Daniels R; Schuett P; Poser M; Mueller S; Ebeling P; Welt A; Bradwell AR; Buttkereit U; Opalka B; Flasshove M; Moritz T; Seeber S
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8706-14. PubMed ID: 16361557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
